Marshall Wace
BNTX icon

Marshall Wace’s BioNTech BNTX Stock Holding History

Marshall Wace’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,500
Closed -$222K – 3188
2026
Q1 		$222K Sell
2,500
-400
-14% -$41.1K ﹤0.01% 2747
2025
Q4 		$276K Sell
2,900
-100
-3% -$10.1K ﹤0.01% 2483
2025
Q3 		$296K Buy
+3,000
New +$321K ﹤0.01% 2433

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Marshall Wace's BNTX Position: Q2 2026 in Review

Marshall Wace increased its BioNTech (BNTX) stake by 53% in Q2 2026, buying an estimated $12.5M and bringing the position to 382,147 shares worth $35.6M. The position accounts for 0.03% of the portfolio, ranked #494.

Marshall Wace first reported a position in BNTX in Q2 2020 and has held it in 18 quarters since. The position peaked at $57.5M in Q4 2022. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Marshall Wace held 382,147 shares of BioNTech worth $35.6M as of Q2 2026.
  • Marshall Wace bought 133,101 BioNTech shares in Q2 2026, an estimated $12.5M.
  • BioNTech made up 0.03% of Marshall Wace's portfolio in Q2 2026, its #494 holding.
  • Marshall Wace first reported a position in BioNTech in Q2 2020 and has held it in 18 quarters since.
  • Marshall Wace's BioNTech position peaked at $57.5M in Q4 2022.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.